Breaking News Instant updates and real-time market news.

FTI

TechnipFMC

$32.28

0.92 (2.93%)

, BEN

Franklin Resources

$33.54

1.06 (3.26%)

09:55
04/12/18
04/12
09:55
04/12/18
09:55

Early notable gainers among liquid option names on April 12th

Notable gainers among liquid option names this morning include FMC Technologies (FTI) $32.54 +1.18, Franklin Resources (BEN) $33.69 +1.21, FMC Corporation (FMC) $80.76 +2.34, Incyte (INCY) $68.21 +1.94, and Signet Jewelers (SIG) $38.75 +1.05.

FTI

TechnipFMC

$32.28

0.92 (2.93%)

BEN

Franklin Resources

$33.54

1.06 (3.26%)

FMC

FMC Corporation

$79.96

1.53 (1.95%)

INCY

Incyte

$66.29

-1.83 (-2.69%)

SIG

Signet Jewelers

$38.30

0.6 (1.59%)

  • 16

    Apr

  • 17

    Apr

  • 23

    Apr

  • 24

    Apr

  • 26

    Apr

  • 03

    May

  • 17

    May

  • 12

    Jun

FTI TechnipFMC
$32.28

0.92 (2.93%)

04/11/18
04/11/18
UPGRADE
Target $39

Buy
TechnipFMC upgraded to Buy with $39 price target at Goldman Sachs
As previously reported, Goldman Sachs analyst Waqar Syed upgraded TechnipFMC to Buy from Neutral and raised his price target on the stock to $39 from $30.50. While his 2018/2019 EBITDA estimates are little changed, his 2020 EBITDA estimates have been raised nearly 18% owing to expectations for higher inbound orders in 2019 for the Subsea and Onshore/Offshore segments. Many upcoming deepwater project awards are with TechnipFMC's alliance partners and LNG awards are with customers with whom TechnipFMC has recently done business, both of which strengthen its positioning for new projects, contends Syed.
04/11/18
GSCO
04/11/18
UPGRADE
GSCO
Buy
TechnipFMC upgraded to Buy from Neutral at Goldman Sachs
01/29/18
01/29/18
DOWNGRADE

Hold
TechnipFMC downgraded to Hold on recent share rally at Societe Generale
As previously reported, Societe Generale downgraded TechnipFMC (FTI) to Hold from Buy. Analyst Guillaume Delaby said shares have recently outperformed and views preliminary 2018 Subsea guidance as too optimistic given mixed news provided by Baker Hughes (BHGE) on its Q4 call, disappointing Q4 order intake, and concerns for flexible pipes.
01/29/18
SOCG
01/29/18
DOWNGRADE
SOCG
Hold
TechnipFMC downgraded to Hold from Buy at Societe Generale
BEN Franklin Resources
$33.54

1.06 (3.26%)

04/09/18
04/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Westlake Chemical (WLK) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. 2. Mettler-Toledo (MTD) downgraded to Neutral from Buy at Goldman Sachs with analyst Patrick Donnelly saying he sees an attractive fundamental backdrop across Tools but is more cautious on the outlook for sales upside at Mettler given his view of a likely moderation of growth in China after a year of catch-up investment in the region. Donnelly also highlights "tough comps" in Labs and Product inspection. 3. Franklin Resources (BEN) downgraded to Neutral from Buy at BofA/Merrill with analyst Michael Carrier saying Franklin's bottom half performance and continued outflows limits organic growth and multiple expansion. 4. NewLink Genetics (NLNK) downgraded to Neutral from Overweight at Cantor Fitzgerald and Baird as well as to Hold from Buy at Jefferies. 5. Incyte (INCY) downgraded to Hold from Buy at Gabelli with analyst Jing He citing the "surprising" failure of the Phase 3 ECHO-301 study in melanoma. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/09/18
BOFA
04/09/18
DOWNGRADE
BOFA
Neutral
Franklin Resources downgraded to Neutral on weak performance at BofA/Merrill
As previously reported, As previously reported, BofA/Merrill downgraded Franklin Resources to Neutral from Buy and cut its price target to $37 from $50. Analyst Michael Carrier believes Franklin's bottom half performance and continued outflows limits organic growth and multiple expansion. Carrier lowered estimates given weaker Q1 markets, increased outflow expectations, and more muted 2018 return expectations.
04/05/18
FBCO
04/05/18
NO CHANGE
Target $34
FBCO
Underperform
Franklin Resources price target lowered to $34 from $39.57 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler lowered his price target for Franklin Resources to $34 from $57 on valuation. The analyst reiterates an Underperform rating on the shares.
04/09/18
BOFA
04/09/18
DOWNGRADE
BOFA
Neutral
Franklin Resources downgraded to Neutral from Buy at BofA/Merrill
FMC FMC Corporation
$79.96

1.53 (1.95%)

04/12/18
BMOC
04/12/18
UPGRADE
BMOC
Outperform
FMC Corporation upgraded to Outperform from Market Perform at BMO Capital
04/12/18
BMOC
04/12/18
UPGRADE
Target $95
BMOC
Outperform
FMC Corporation upgraded to Outperform at BMO Capital on improving ag view
As reported earlier, BMO Capital analyst Joel Jackson upgraded FMC Corporation to Outperform from Market Perform and raised his price target to $95 from $90. Jackson says greater exposure to the agricultural sector is warranted given the apparent trough in the ag/grower sentiment. The analyst also points to "similar or lower" valuation multiple for FMC relative to other ag/fertilizer/commodity chemical stocks, adding that the "15% lithium mix" should provide a "higher multiple kicker". Jackson also raised his FY18 EPS view to $5.70 from $5.50, reflecting the company's March 29th upgrade in earnings guidance.
04/02/18
SBSH
04/02/18
NO CHANGE
SBSH
Buy
Citi finds FMC management most bullish on Mid-Atlantic tour
After meeting with senior management teams from Air Products (APD), FMC Corporation (FMC), PQ Group (PQG), Calyxt (CLXT) and AgroFresh Solutions (AGFS), Citi analyst P.J. Juvekar says FMC was the most bullish. FMC management highlighted strength in the company's Ag business and the ongoing integration from the DuPont acquisition, Juvekar tells investors in a research note. The analyst raised his estimates for FMC "across the board" on better Ag execution and calls the stock one of our top three ideas. On Air Products, the analyst is "getting more comfortable with the risk/reward of Chinese coal gasification projects." On PQ Group, Juvekar views the recent share pullback as overdone. The company delivered "two solid consecutive quarters" since the initial public offering and has made strides in reducing debt, the analyst contends.
02/15/18
02/15/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he has become more optimistic on the immuno-oncology Opdivo + Yervoy combo in first-line lung cancer, which he notes is the largest cancer market. 2. Salesforce (CRM) upgraded to Buy from Hold at Jefferies with analyst John DiFucci saying recent field checks indicate continued strong enterprise traction as well improved commercial segment momentum, likely due to moderating Microsoft (MSFT) competition. 3. Credit Suisse (CS) upgraded to Buy from Hold at Societe Generale. 4. FMC Corporation (FMC) upgraded to Buy from Neutral at Seaport Global with analyst Michael Harrison saying he sees near-term catalysts from the Ag market recovery and secular growth in lithium, which the company plans to spinoff. 5. Baidu (BIDU) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Grace Chen citing expectations for search sales reacceleration in 2018, the potential catalyst of the iQiyi IPO and the long-term potential contributions from AI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
INCY Incyte
$66.29

-1.83 (-2.69%)

04/10/18
MZHO
04/10/18
NO CHANGE
Target $27
MZHO
Buy
Concert still likely to win IPR challenge against Incyte, says Mizuho
Mizuho analyst Difei Yang does not see a read-through to the final decision from the Patent Trial and Appeal Board's granting Incyte's (INCY) motion for reconsideration as it relates to the Inter Partes Review Petition challenge against Concert Pharmaceuticals (CNCE). The analyst still thinks Concert is likely to win the challenge based on how it has defended its patents historically. The company has an "impressive track record" on intellectual protection front, Yang tells investors in a research note. The analyst reiterates a Buy rating on Concert Pharmaceuticals with a $27 price target. The stock in morning trading is down 5%, or 96c, to $19.08.
04/12/18
UBSW
04/12/18
UPGRADE
Target $76
UBSW
Buy
Incyte upgraded to Buy from Neutral at UBS
UBS analyst Carter Gould upgraded Incyte (INCY) to Buy while lowering his price target for the shares to $76 from $106. The stock offers an improved risk/reward profile after resetting lower on negative epacadostat Phase 3 data and removal of the drug from analyst models, Gould tells investors in a research note. The focus on epacadostat "obscured an otherwise solid, profitable, and strategically attractive Jakafi franchise," the analyst contends. He believes the base business alone supports $65 per share, even before considering its "compelling strategic attractiveness." Incyte closed yesterday down $1.83 to $66.29. Gould thinks clinical catalysts against low expectations can drive $13-$17 per share of upside over 2018.
04/09/18
RHCO
04/09/18
NO CHANGE
Target $80
RHCO
Buy
Incyte price target lowered to $80 from $155 at SunTrust
SunTrust analyst Peter Lawson slashed his price target on Incyte to $80 after the failure of phase 3 IDO study in melanoma, saying that he is removing all IDO indicators from his model while also sharply discounting the post-IDO pipeline. While the analyst warns that further negative news related to IDO readouts could be coming, the post-failure stock price decline does create some "underlying value", keeping his Buy rating on Incyte.
SIG Signet Jewelers
$38.30

0.6 (1.59%)

03/20/18
03/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oracle (ORCL) downgraded to Neutral from Buy at BofA/Merrill and to Hold from Buy at Stifel. 2. Huntsman (HUN) downgraded to Neutral from Buy at Nomura Instinet with analyst Aleksey Yefremov saying he believes the shares are unlikely to outperform until demand for MDI-based polyurethanes markets finds a bottom. 3. Signet Jewelers (SIG) downgraded to Neutral from Buy at BofA/Merrill with analyst Lorraine Hutchinson saying Signet lacks growth visibility near-term and lowered estimates to reflect a weak base business, credit transition issues, and a loss of EBIT from subprime credit outsourcing. 4. Dominion (D) downgraded to Neutral from Buy at BofA/Merrill with analyst Julien Dumoulin-Smith saying the latest FERC policy changes is a headwind to Dominion's dropdown desire into Dominion Midstream (DM) and could impact valuations of midstream assets. 5. Essex Property Trust (ESS) downgraded to Hold from Buy at SunTrust with analyst Michael Lewis saying the stock's recent outperformance has narrowed its discount to NAV to the smallest margin among its peers, even though its leverage and earnings growth rate are comparable to those of peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/18
BOFA
03/20/18
DOWNGRADE
BOFA
Neutral
Signet Jewelers downgraded to Neutral from Buy at BofA/Merrill
03/20/18
JPMS
03/20/18
NO CHANGE
Target $40
JPMS
Neutral
Signet Jewelers price target lowered to $40 from $52 at JPMorgan
JPMorgan analyst Matthew Boss lowered his price target for Signet Jewelers to $40 saying the company's transitional investments will take time to pay dividends. The analyst sees the combination of negative traffic and fiscal 2019 store closures "weighing on the top-line profile" through at least fiscal 2020. Boss keeps a Neutral rating on Signet shares.
03/20/18
03/20/18
DOWNGRADE
Target $43

Neutral
Signet Jewelers downgraded to Neutral on lack of visibility at BofA/Merrill
As previously reported, BofA/Merrill downgraded Signet Jewelers to Neutral from Buy and cut its price target to $43 from $66. Analyst Lorraine Hutchinson said Signet lacks growth visibility near-term and lowered estimates to reflect a weak base business, credit transition issues, and a loss of EBIT from subprime credit outsourcing. Hutchinson said it will take time for new initiatives to be effective and drive comps and notes management expects the credit transition to remain a headwind all year to sales growth.

TODAY'S FREE FLY STORIES

KORS

Michael Kors

$68.63

0.25 (0.37%)

, LULU

Lululemon

$106.18

-0.19 (-0.18%)

11:07
05/26/18
05/26
11:07
05/26/18
11:07
Periodicals
Dollar Tree looks interesting, Barron's says »

Next week, another 20…

KORS

Michael Kors

$68.63

0.25 (0.37%)

LULU

Lululemon

$106.18

-0.19 (-0.18%)

GME

GameStop

$12.64

-0.1 (-0.78%)

DLTR

Dollar Tree

$95.23

0.59 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 12

    Jun

  • 14

    Jun

  • 26

    Jun

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

, QCOM

Qualcomm

$59.95

0.85 (1.44%)

10:58
05/26/18
05/26
10:58
05/26/18
10:58
Periodicals
Kraft Heinz, J&J among safe, 'solid' dividend stocks, Barron's says »

Kraft Heinz (KHC),…

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

QCOM

Qualcomm

$59.95

0.85 (1.44%)

MRK

Merck

$59.08

-0.03 (-0.05%)

TGT

Target

$71.22

0.28 (0.39%)

OMC

Omnicom

$71.98

-0.1 (-0.14%)

CCL

Carnival

$64.27

0.12 (0.19%)

JNJ

Johnson & Johnson

$121.40

0.06 (0.05%)

MMM

3M

$198.98

-0.38 (-0.19%)

LLY

Eli Lilly

$82.75

0.05 (0.06%)

VLO

Valero

$118.81

-3.06 (-2.51%)

EMR

Emerson

$72.50

-0.77 (-1.05%)

WBA

Walgreens Boots Alliance

$63.52

0.09 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 02

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 19

    Jun

  • 10

    Sep

  • 23

    Oct

MU

Micron

$61.33

-0.15 (-0.24%)

10:48
05/26/18
05/26
10:48
05/26/18
10:48
Periodicals
Micron can solve low valuation, Barron's says »

Micron's stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ATUS

Altice USA

$18.50

-0.05 (-0.27%)

10:40
05/26/18
05/26
10:40
05/26/18
10:40
Periodicals
Altice's spinoff could be winning bet, Barron's says »

On June 8, Altice will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

MU

Micron

$61.33

-0.15 (-0.24%)

, XLNX

Xilinx

$69.63

0.88 (1.28%)

10:35
05/26/18
05/26
10:35
05/26/18
10:35
Periodicals
AI revolution just getting started, Barron's says »

Artificial Intelligence…

MU

Micron

$61.33

-0.15 (-0.24%)

XLNX

Xilinx

$69.63

0.88 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

08:08
05/26/18
05/26
08:08
05/26/18
08:08
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

HMC

Honda

$32.04

-0.34 (-1.05%)

NSANY

Nissan

$0.00

(0.00%)

F

Ford

$11.51

-0.11 (-0.95%)

GM

General Motors

$38.30

-0.09 (-0.23%)

TM

Toyota

$129.97

-2.47 (-1.87%)

VLKAY

Volkswagen

$0.00

(0.00%)

BAC

Bank of America

$30.16

-0.03 (-0.10%)

C

Citi

$68.42

-0.86 (-1.24%)

GS

Goldman Sachs

$235.05

-1.1 (-0.47%)

JPM

JPMorgan

$110.62

-0.64 (-0.58%)

MS

Morgan Stanley

$53.02

-0.96 (-1.78%)

USB

U.S. Bancorp

$50.54

-0.14 (-0.28%)

WFC

Wells Fargo

$54.91

0.25 (0.46%)

TWTR

Twitter

$33.64

0.11 (0.33%)

AA

Alcoa

$47.92

-1.26 (-2.56%)

CENX

Century Aluminum

$16.27

-0.07 (-0.43%)

AOBC

American Outdoor Brands

$12.53

0.05 (0.40%)

RGR

Sturm, Ruger

$63.10

0.5 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 06

    Jun

  • 20

    Jun

  • 22

    Jun

  • 13

    Jul

  • 27

    Jul

  • 10

    Sep

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 15

    Jul

  • 15

    Oct

HCLP

Hi-Crush Partners

$13.20

-0.825 (-5.88%)

17:54
05/25/18
05/25
17:54
05/25/18
17:54
Hot Stocks
Hi-Crush Partners provides update on bulldozer incident in Whitehall facility »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$77.98

1.49 (1.95%)

17:37
05/25/18
05/25
17:37
05/25/18
17:37
Hot Stocks
Post Holdings reports fire in Michael Foods' plant in Pennsylvania »

Post Holdings reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:34
05/25/18
05/25
17:34
05/25/18
17:34
Hot Stocks
Abiomed to enter S&P 500 index on May 31 »

S&P MidCap 400…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

PRAH

PRA Health

$81.19

0.33 (0.41%)

GME

GameStop

$12.64

-0.1 (-0.78%)

FRED

Fred's

$1.69

0.05 (3.05%)

PRSP

Symbol now PB

$0.00

(0.00%)

RRTS

Roadrunner

$2.19

0.04 (1.86%)

DXC

DXC Technology

$94.20

-5.42 (-5.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 12

    Jun

PRAH

PRA Health

$81.19

0.33 (0.41%)

, ABMD

Abiomed

$394.49

0.04 (0.01%)

17:24
05/25/18
05/25
17:24
05/25/18
17:24
Hot Stocks
Breaking Hot Stocks news story on PRA Health, Abiomed »

PRA Health to replace…

PRAH

PRA Health

$81.19

0.33 (0.41%)

ABMD

Abiomed

$394.49

0.04 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

WYN

Wyndham

$107.98

-0.58 (-0.53%)

, MSCC

Microsemi

$68.74

0.005 (0.01%)

17:23
05/25/18
05/25
17:23
05/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Wyndham, Microsemi »

Wyndham to replace…

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:21
05/25/18
05/25
17:21
05/25/18
17:21
Hot Stocks
Breaking Hot Stocks news story on Abiomed, Wyndham »

ABIOMED to replace…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

PCG

PG&E

$44.67

0.84 (1.92%)

17:16
05/25/18
05/25
17:16
05/25/18
17:16
Periodicals
CA Forestry Dept rules PG&E equipment responsible for wildfires, Bloomberg says »

Report filed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$28.50

0.15 (0.53%)

17:09
05/25/18
05/25
17:09
05/25/18
17:09
Hot Stocks
Levin Capital Strategies reports 8.4% stake in Farmer Bros »

Levin Capital purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:07
05/25/18
05/25
17:07
05/25/18
17:07
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.22

-0.125 (-9.29%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Hot Stocks
Windstream completes one-for-five reverse stock split »

Windstream completed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPD

Enterprise Products

$27.87

-0.12 (-0.43%)

17:01
05/25/18
05/25
17:01
05/25/18
17:01
Hot Stocks
Enterprise Products conduts open season for West Texas Crude oil expansion »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INO

Inovio

$4.89

0.06 (1.24%)

16:37
05/25/18
05/25
16:37
05/25/18
16:37
Syndicate
Breaking Syndicate news story on Inovio »

Inovio files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$10.14

0.13 (1.30%)

16:36
05/25/18
05/25
16:36
05/25/18
16:36
Hot Stocks
Rent-A-Center 16.8% shareholder Engaged Capital nominates Carol McFate to Board »

On May 25, 2018, Engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$0.59

0.0086 (1.48%)

16:34
05/25/18
05/25
16:34
05/25/18
16:34
Hot Stocks
Akers Biosciences receives delinquency notice from NASDAQ »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$6.60

0.37 (5.94%)

16:31
05/25/18
05/25
16:31
05/25/18
16:31
Hot Stocks
Ditech discloses receipt of late filing notice from NYSE »

Ditech Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$28.15

-4.82 (-14.62%)

, FL

Foot Locker

$55.97

9.585 (20.67%)

16:30
05/25/18
05/25
16:30
05/25/18
16:30
General news
On The Fly: Top stock stories for Friday »

Stocks on Wall Street…

GPS

Gap

$28.15

-4.82 (-14.62%)

FL

Foot Locker

$55.97

9.585 (20.67%)

HLF

Herbalife Nutrition

$48.76

-5.09 (-9.45%)

IEP

Icahn Enterprises

$69.41

0.22 (0.32%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

DGX

Quest Diagnostics

$105.89

5 (4.96%)

UNH

UnitedHealth

$244.96

2.23 (0.92%)

ROST

Ross Stores

$77.35

-5.6 (-6.75%)

ADSK

Autodesk

$132.80

-5.96 (-4.30%)

AAL

American Airlines

$44.89

1.34 (3.08%)

LUV

Southwest

$52.86

1.65 (3.22%)

DAL

Delta Air Lines

$55.89

1.48 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 29

    Jun

16:30
05/25/18
05/25
16:30
05/25/18
16:30
Options
Preliminary option volume of 16.4M today »

Preliminary option volume…

VTL

Vital Therapies

$5.65

-0.475 (-7.76%)

16:26
05/25/18
05/25
16:26
05/25/18
16:26
Syndicate
Breaking Syndicate news story on Vital Therapies »

Vital Therapies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.